Trial intelligence / Profile preview

Antiseptic Effects on the Dental Implant Internal Surface Microbiome

NCT05024760Phase 1Completed

Sponsor
Madigan Army Medical Center
Start
Jul 2022
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of chlorhexidine + cymenol gel and hydrogen peroxide gel in peri-implantitis and peri-implant mucositis (3 arms), sponsored by Madigan Army Medical Center. Primary endpoint: Implant Failure at 4 months. Started Jul 2022; status: completed.

02

Drugs

chlorhexidine + cymenol gelhydrogen peroxide gel
03

Conditions

peri-implantitisperi-implant mucositis

Beyond the preview

Go deeper on NCT05024760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05024760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call